This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1974 Jul 4;291(1):26-35.

doi: 10.1056/NEJM197407042910109.

The origin and development of human tumors studied with cell markers

PMID: 4598924
DOI: 10.1056/NEJM197407042910109

Review

The origin and development of human tumors studied with cell markers

P J Fialkow. N Engl J Med. 1974.

. 1974 Jul 4;291(1):26-35.

doi: 10.1056/NEJM197407042910109.

Author

PMID: 4598924
DOI: 10.1056/NEJM197407042910109

No abstract available

PubMed Disclaimer

Similar articles

Clonal origin of human tumors.
Fialkow PJ. Fialkow PJ. Biochim Biophys Acta. 1976 Oct 12;458(3):283-321. doi: 10.1016/0304-419x(76)90003-2. Biochim Biophys Acta. 1976. PMID: 1067873 No abstract available.
Human tumors studied with genetic markers.
Fialkow PJ. Fialkow PJ. Birth Defects Orig Artic Ser. 1976;12(1):123-32. Birth Defects Orig Artic Ser. 1976. PMID: 825156
Chronic myelocytic leukemia. Origin of some lymphocytes from leukemic stem cells.
Fialkow PJ, Denman AM, Jacobson RJ, Lowenthal MN. Fialkow PJ, et al. J Clin Invest. 1978 Oct;62(4):815-23. doi: 10.1172/JCI109193. J Clin Invest. 1978. PMID: 308953 Free PMC article.
The suppressor-cell network in cancer (second of two parts).
Broder S, Waldmann TA. Broder S, et al. N Engl J Med. 1978 Dec 14;299(24):1335-41. doi: 10.1056/NEJM197812142992404. N Engl J Med. 1978. PMID: 362202 Review. No abstract available.
Use of genetic markers to study cellular origin and development of tumors in human females.
Fialkow PJ. Fialkow PJ. Adv Cancer Res. 1972;15:191-226. doi: 10.1016/s0065-230x(08)60375-9. Adv Cancer Res. 1972. PMID: 4621753 Review. No abstract available.

See all similar articles

Cited by

Stability of X chromosomal inactivation in human somatic cells transformed by SV-40.
Romeo G, Migeon BR. Romeo G, et al. Humangenetik. 1975 Sep 10;29(2):165-70. doi: 10.1007/BF00430356. Humangenetik. 1975. PMID: 170191
Prevalence and clinical significance of combined K-ras mutation and p53 aberration in pancreatic adenocarcinoma.
Dergham ST, Dugan MC, Kucway R, Du W, Kamarauskiene DS, Vaitkevicius VK, Crissman JD, Sarkar FH. Dergham ST, et al. Int J Pancreatol. 1997 Apr;21(2):127-43. doi: 10.1007/BF02822384. Int J Pancreatol. 1997. PMID: 9209954
Cancer and ageing in mice and men.
Peto R, Roe FJ, Lee PN, Levy L, Clack J. Peto R, et al. Br J Cancer. 1975 Oct;32(4):411-26. doi: 10.1038/bjc.1975.242. Br J Cancer. 1975. PMID: 1212409 Free PMC article.
Extrapolation of carcinogenic risk from animal experiments in man.
Ehrenberg L, Holmberg B. Ehrenberg L, et al. Environ Health Perspect. 1978 Feb;22:33-5. doi: 10.1289/ehp.782233. Environ Health Perspect. 1978. PMID: 648489 Free PMC article.
Novel Phenotypic Fluorescent Three-Dimensional Co-Culture Platforms for Recapitulating Tumor in vivo Progression and for Personalized Therapy.
Fang C, Man YG, Cuttitta F, Stetler-Stevenson W, Salomon D, Mazar A, Kulesza P, Rosen S, Avital I, Stojadinovic A, Jewett A, Jiang B, Mulshine J. Fang C, et al. J Cancer. 2013 Dec 1;4(9):755-63. doi: 10.7150/jca.7813. eCollection 2013. J Cancer. 2013. PMID: 24312145 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.